DR30318, a novel tri-specific T cell engager for Claudin 18.2 positive cancers immunotherapy
DR30318,一种用于 Claudin 18.2 阳性癌症免疫治疗的新型三特异性 T 细胞接合剂
期刊:Cancer Immunology Immunotherapy
影响因子:8.1
doi:10.1007/s00262-024-03673-x
Zhe Ma #, Zhenxing Zhou #, Wenwen Duan, Gaofeng Yao, Shimei Sheng, Sidou Zong, Xin Zhang, Changkui Li, Yuanyuan Liu, Fengting Ou, Maha Raja Dahar, Yanshan Huang, Lushan Yu